header-20.jpg
Events

APCRC - Q Seminar Series

Featuring the research of Dr Brett Hollier, a Senior Research Fellow at the Australian Prostate Cancer Research Centre - Queensland.
Event Type Seminar
When Nov 20, 2012
from 09:30 PM to 11:30 PM
Where Russell Strong Auditorium
Contact Name
Contact Phone 3176 7957
Add event to calendar vCal
iCal

APCRC_Q_Staff192_brett.jpg

Dr Brett Hollier

  • Senior Research Fellow, APCRC-Q
  • Research Fellow & Group Leader - IGF Mechanistic studies, Tissue Repair & Regeneration Program, IHBI, QUT


“Targeting epithelial plasticity to improve therapies for advanced prostate cancer”

Dr Brett Hollier is an early career researcher with an interest in understanding the mechanisms that mediate cancer metastasis. In particular, his research focuses on the Insulin-like Growth Factor (IGF) family and the epithelial-to-mesenchymal transition (EMT) program. Dr Hollier joined the Australian Prostate Cancer Research Centre - Queensland (APCRC-Q) earlier this year after returning to Australia in late 2010 following his 2 year postdoctoral position at the M.D Anderson Cancer Centre (MDACC) in Houston, USA. While at MDACC, Dr Hollier was awarded a Susan G Komen for the Cure® Foundation Postdoctoral Fellowship (USA) for his research investigating the role of EMT in cancer stem cells and breast cancer metastasis. More recently, he was awarded a 3 year fellowship to design smarter targeted therapies for cancer progression.

Dr Martin Sadowski

Dr Martin Sadowski

  • Postdoctoral Research Fellow, APCRC - Q


“Evaluation of the fatty acid synthase inhibitor triclosan in prostate cancer”

Upon completion of his PhD, investigating the relationship between mRNA processing and transcription termination, at the Biozentrum, University of Basel, Switzerland, Dr Sadowski joined the Cancer Program at the Garvan Institute of Medical Research in Sydney. In late 2004 he moved with the laboratory to St. Vincent’s Institute of Medical Research in Melbourne, where he continued his postdoctoral research on enzymes of the ubiquitination pathway. He joined the APCRC –Q as a research fellow in late 2010, where his research focuses on the identification and therapeutic targeting of molecular pathways that are responsible for the development of castrate-resistant prostate cancer.

poster for printing

Russell Strong Auditorium
Basement Level Main Building
Princess Alexandra Hospital
Brisbane

Refreshments: from 4.30pm
Presentations: 5.00pm-6.00pm
Networking: 6.00pm-6:30pm

RSVP for catering purposes:
prostatecentre@qut.edu.au